[Tuberculous pleurisy after tumour necrosis factor-alpha antagonist usage: case report]

Tuberk Toraks. 2008;56(4):448-52.
[Article in Turkish]

Abstract

A thirty-six year old male patient presented with dyspnea, right-sided chest pain, night sweats and intermittent fever. He has a history of ankylosing spondylitis treated with tumour necrosis factor-alpha (TNF-alpha) antagonist (infliximab). Computed tomography of the chest showed mediastinal lymphadenopathy, right-sided pleural effusion, and atelectasis. The pleural fluid was exudative with lymphocyte dominance. Closed pleural biopsy was nondiagnostic. The adenosine deaminase level of the pleural fluid was 110 U/L. In light of these findings, the patient was diagnosed as tuberculous pleurisy and antituberculous treatment was given. After one month, pleural fluid was markedly reduced.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adult
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Antitubercular Agents / therapeutic use*
  • Humans
  • Infliximab
  • Male
  • Pleural Effusion / cytology
  • Pleural Effusion / drug therapy
  • Pleural Effusion / etiology*
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Tuberculosis, Pleural / chemically induced*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antitubercular Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab